Correlation Between Tandem Diabetes and Nexalin Technology
Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tandem Diabetes Care and Nexalin Technology, you can compare the effects of market volatilities on Tandem Diabetes and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and Nexalin Technology.
Diversification Opportunities for Tandem Diabetes and Nexalin Technology
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tandem and Nexalin is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and Nexalin Technology go up and down completely randomly.
Pair Corralation between Tandem Diabetes and Nexalin Technology
Given the investment horizon of 90 days Tandem Diabetes Care is expected to under-perform the Nexalin Technology. But the stock apears to be less risky and, when comparing its historical volatility, Tandem Diabetes Care is 5.61 times less risky than Nexalin Technology. The stock trades about -0.03 of its potential returns per unit of risk. The Nexalin Technology is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 36.00 in Nexalin Technology on September 2, 2024 and sell it today you would earn a total of 26.00 from holding Nexalin Technology or generate 72.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tandem Diabetes Care vs. Nexalin Technology
Performance |
| Timeline |
| Tandem Diabetes Care |
| Nexalin Technology |
Tandem Diabetes and Nexalin Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tandem Diabetes and Nexalin Technology
The main advantage of trading using opposite Tandem Diabetes and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.| Tandem Diabetes vs. DexCom Inc | Tandem Diabetes vs. Inspire Medical Systems | Tandem Diabetes vs. Penumbra | Tandem Diabetes vs. Insulet |
| Nexalin Technology vs. NexGel Warrant | Nexalin Technology vs. NLS Pharmaceutics AG | Nexalin Technology vs. Inspira Technologies Oxy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |